Boston BioSystems commences operations -- signs contract with Pharmacia Biotech.BEDFORD, Mass.--(BUSINESS WIRE)--Sept. 23, 1996-- Boston BioSystems announced today that it has commenced operations at its facility in Bedford, Mass. The company's initial focus is to provide contract custom synthesis of DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. and RNA RNA: see nucleic acid. RNA in full ribonucleic acid One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic , for pharmaceutical and diagnostic applications, using its GMP-conforming plant. The company recently signed a three year contract with Pharmacia Biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. , a recognized leader in biopharmaceutical products. Later, the company's plan is to use their technology and experience to develop a line of automated instruments and disposables for making DNA, RNA and peptides for sale to the biotech and pharmaceutical research markets around the world. Jack Johansen, Boston BioSystems CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. and chairman, said, "We started out with a real advantage because our team is made up largely of people form Millipore where they gathered a lot of experience in our field. I'm sure that's one of the reasons Pharmacia gave us such a vote of confidence early on with the awarding of this contract. In fact, we are occupying the facility that many of us helped design and operate there." He continued, "The high level of interest focused on antisense antisense, DNA or RNA manipulated in a laboratory so that its components (nucleotides) form a complementary copy of normal, or "sense," messenger RNA (mRNA; see nucleic acid). therapeutics, which use synthetic DNA and RNA, give us a growing market with recognized potential. We plan to us the revenue stream from such contract synthesis sales to fund the development of our own instruments and chemicals, including products to meet the exciting demands of drug research for combinatorial chemistry Combinatorial chemistry involves the rapid synthesis or the computer simulation of a large number of different but structurally related molecules. Introduction Synthesis of molecules in a combinatorial fashion can quickly lead to large numbers of molecules. applications." CONTACT: Boston BioSystems Dr. Jack Johansen, 617/271-1580 ext. 222 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion